The Phase 3 BEACON clinical trial, which is testing the experimental therapy rugonersen in people with Angelman syndrome, has begun dosing participants. Oak Hill Bio, the company developing rugonersen and sponsoring the trial, announced that the first participant had been dosed in late July. The trial is currently…
Discussion
It’s the middle of winter here in Australia. Runny noses, coughs, and viruses have made their way through households across the country, and ours was no exception. So it wasn’t a surprise when our 3-year-old son, Jude, who lives with Angelman syndrome, recently developed a fever and had a…
Discussion
Enrollment of the first group of participants in a Phase 3 clinical trial testing obudanersen in people with Angelman syndrome is complete, with 136 children taking part in the study to determine whether the treatment can improve communication. The REVEAL study (NCT06914609) will evaluate the therapy in kids and adults.
Becoming educated and informed about Angelman syndrome is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your Angelman syndrome journey.
There is no cure for Angelman syndrome yet, but there are treatments that can help manage the disease. Learn more about the approved and experimental therapies here.
Get regular updates to your inbox.
